Trial Watch: Inhibiting PARP enzymes for anticancer therapy - Molecular & Cellular Oncology

open access

 June 10, 2016

ABSTRACT

Introduction

PARP activity and cancer

PARP1 in cancer therapy

Clinical investigation of PARP inhibitors

Concluding remarks

Table 2. Ongoing clinical trials recently launched to evaluate the safety and efficacy of PARP inhibitors in cancer patients.